NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed Nov 4, 2003
Insider Transaction Report
Form 4
SISKOWSKI GARY A
Sr. VP Sales & Marketing
Transactions
- Other
Common Stock
2003-05-31$5.94/sh+164.1$975→ 2,540.945 total
Holdings
- 245(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.